小泉 賢洋

Masahiro Koizumi

  • 講師
  • 学位:博士(医学)

基本情報

所属

  • Undergraduate School of Medicine / Faculty of Medicine

詳細情報

研究分野

  • Life sciences Nephrology

論文

A case of ANCA-negative pauci-immune crescentic glomerulonephritis with lung adenocarcinoma with mediastinal involvement successfully treated by corticosteroid and radiation therapy.

Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020

Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists.

Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists.

Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists.

Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.

C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.

Podocytes are lost from glomeruli before completing apoptosis.

Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020

Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.

書籍等出版物

  • 腎臓におけるアンジオテンシン 制御と局在
  • 骨髄移植後、遅発性に高度蛋白尿と腎障害を呈した放射線腎症の一例
  • 著明な紫斑を伴うANCA陰性の顕微鏡的多発血管炎(MPA)の一例
  • リツキシマブが著効を示したIgA沈着を伴ったFSGSの一例
  • Biochemical markers of bone turnover

共同研究・競争的資金等の研究課題

Inflammation-like reactions within podocytes caused by mitochondrial stress

The development of a novel therapy for glomerulosclerosis by metabolic modulation of collagen

Revisit of glomerulosclerosis

ResearchMapへ移動します

Contact Us

Inquiries about coverage

Public Affairs Division Public Affairs and Communications Department

Tel. 0463-63-4670(direct dialing)